Cranmer, a UW–Madison alumnus and executive director of the Moore-Sloan Data Science Environment at NYU, played a significant role in the discovery of the Higgs boson.
Researchers in the School of Pharmacy, led by Quanyin Hu, have developed a system that can keep probiotic bacteria alive in the lower intestine long enough to help treat or prevent colitis in a mouse model of the disease.
“There are very few places on the globe where you have the collection of expertise with fungi that we have at UW–Madison,” says Anne Pringle, a professor of botany.
New research findings from the UW, NOAA and others may change the way scientists predict how cloud formation responds to changes in the oceans.
The research is funded through an $11 million Transformative Research grant from the National Institutes of Health, which supports exceptionally innovative or unconventional research projects with the potential to advance their field.
With high-risk, high-reward investment, UW–Madison researcher seeks to outwit cancer’s resistance to treatment
Sequencing the tumor samples’ genetic material will allow the researchers to map changes in individual tumors that became resistant and discern possible common mechanisms of resistance across multiple tumors.
“For many, many lakes, they are a very serious problem,” says Grace Wilkinson of the UW–Madison Center for Limnology. “But algal blooms are not getting worse everywhere."
The initiative builds on the strengths of existing library holdings, while also expanding campus research capacities with critical and emerging collections needs.
UW researchers have uncovered a key feature of breast cancers that renders them either vulnerable or resistant to paclitaxel treatment, which could help identify which patients are most likely to see success.
The research could help national governments and other agencies direct limited resources toward those areas at greatest risk of deforestation, which threatens biodiversity and releases large amounts of carbon dioxide into the atmosphere.
Research activities delayed or negatively affected by the COVID-19 pandemic are eligible to apply for the Pandemic-Affected Research Continuation Initiative.